Massachusetts Financial Services’s Salarius Pharmaceuticals SLRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q2 | – | Sell |
-5
| Closed | -$1.86M | – | 864 |
|
2018
Q1 | $1.86M | Hold |
5
| – | – | ﹤0.01% | 706 |
|
2017
Q4 | $1.28M | Hold |
5
| – | – | ﹤0.01% | 731 |
|
2017
Q3 | $1.24M | Hold |
5
| – | – | ﹤0.01% | 725 |
|
2017
Q2 | $1.39M | Hold |
5
| – | – | ﹤0.01% | 729 |
|
2017
Q1 | $1.59M | Hold |
5
| – | – | ﹤0.01% | 718 |
|
2016
Q4 | $1.91M | Hold |
5
| – | – | ﹤0.01% | 725 |
|
2016
Q3 | $4.27M | Hold |
5
| – | – | ﹤0.01% | 665 |
|
2016
Q2 | $3.64M | Buy |
5
+2
| +67% | +$1.45M | ﹤0.01% | 677 |
|
2016
Q1 | $2.79M | Hold |
3
| – | – | ﹤0.01% | 688 |
|
2015
Q4 | $3.13M | Hold |
3
| – | – | ﹤0.01% | 690 |
|
2015
Q3 | $3.04M | Hold |
3
| – | – | ﹤0.01% | 698 |
|
2015
Q2 | $4.35M | Hold |
3
| – | – | ﹤0.01% | 682 |
|
2015
Q1 | $5.04M | Buy |
+3
| New | +$5.04M | ﹤0.01% | 668 |
|